RNA-Binding Protein Musashi1 Is a Central Regulator of Adhesion Pathways in Glioblastoma
Author(s) -
Philip J. Uren,
Dat T. Vo,
Patricia Rosa De Araujo,
Rebecca Pötschke,
Suzanne Burns,
Emad BahramiSamani,
Mei Qiao,
Raquel de Sousa Abreu,
Helder I. Nakaya,
Bruna Corrêa,
Caspar D. Kühnöl,
Jernej Ule,
Jennifer L. Martindale,
Kotb Abdelmohsen,
Myriam Gorospe,
Andrew D. Smith,
Luiz O. F. Penalva
Publication year - 2015
Publication title -
molecular and cellular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.14
H-Index - 327
eISSN - 1067-8824
pISSN - 0270-7306
DOI - 10.1128/mcb.00410-15
Subject(s) - biology , rna binding protein , regulator , context (archaeology) , rna , rna splicing , computational biology , untranslated region , alternative splicing , genetics , gene , microbiology and biotechnology , cancer research , messenger rna , paleontology
The conserved RNA-binding protein Musashi1 (MSI1) has emerged as a key oncogenic factor in numerous solid tumors, including glioblastoma. However, its mechanism of action has not yet been established comprehensively. To identify its target genes comprehensively and determine the main routes by which it influences glioblastoma phenotypes, we conducted individual-nucleotide resolution cross-linking and immunoprecipitation (iCLIP) experiments. We confirmed that MSI1 has a preference for UAG sequences contained in a particular structural context, especially in 3' untranslated regions. Although numerous binding sites were also identified in intronic sequences, our RNA transcriptome sequencing analysis does not favor the idea that MSI1 is a major regulator of splicing in glioblastoma cells. MSI1 target mRNAs encode proteins that function in multiple pathways of cell proliferation and cell adhesion. Since these associations indicate potentially new roles for MSI1, we investigated its impact on glioblastoma cell adhesion, morphology, migration, and invasion. These processes are known to underpin the spread and relapse of glioblastoma, in contrast to other tumors where metastasis is the main driver of recurrence and progression.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom